Resilience and Adaptation: Investment Metrics of Indonesian Healthcare Companies Before and During the COVID-19 Pandemic

Abstract

The impact of dividend policy and stock valuation (price earning proportion and price to book value) on the prices of healthcare industry stocks listed on the Indonesia Stock Trade somewhere in the range of 2016 and 2021 is examined in this study. The research data used in this quantitative analysis are secondary data. This study included eighteen healthcare sector companies in its sample. Purposive sampling is the methodology used in this study, and SPSS 24 is the analysis tool. We explained the relationship between stock prices, dividend policy, and stock valuation. We order the variables into pre-pandemic and during-pandemic categories subsequent to testing them for like clockwork. That's what the experimental results demonstrate, for all periods, the earning-per-share notation has a significant impact on stock prices. Stock valuation, on the other hand, has a significant impact on stock prices, as does the final dividend policy with dividend payout proportion and dividend per share. Meanwhile, results from the pre-pandemic time frame indicate that EPS and DPR didn't significantly influence results; results from the pandemic time frame indicate that stock valuation didn't significantly influence stock price. This research provides fresh insights into what the recovery of economic exposure means for corporate conduct in Indonesia, where persistent financial and economic pressures from stock market unpredictability give substantial sources of uncertainty.